Evotec SE (EVO) EBITDA Margin (2009 - 2025)
Evotec SE's (EVO) quarterly EBITDA Margin came in at 22.9% in Q4 2025, up 1001.0% year-over-year from 2.08% in Q4 2024, and up 184.33% quarter-over-quarter from 27.15% in Q3 2025.
Powered by 
Analysis
Evotec SE (EVO) EBITDA Margin (2009 - 2025) Analysis & Trends
Evotec SE has disclosed EBITDA Margin across 9 years of filings, most recently posting 22.9% for Q4 2025.
- In Q4 2025, EBITDA Margin rose 1001.0% year-over-year to 22.9%; the TTM figure through Dec 2025 stood at 12.23% (up 5666.0% YoY), while the FY2025 annual figure was 0.01%, changed 0.0% from the prior year.
- EBITDA Margin came in at 22.9% for Q4 2025 at Evotec SE, up from 27.15% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 11109.79% in Q3 2021 to a low of 27.15% in Q3 2025.
- Average EBITDA Margin over 5 years is 620.97%, with a median of 6.38% recorded in 2022.
- Year-over-year, EBITDA Margin tumbled 1110201 bps in 2022 and soared 6720 bps in 2024.
- Over 5 years, EBITDA Margin stood at 0.01% in 2021, then surged by 76902 bps to 8.73% in 2022, then retreated by 1 bps to 8.66% in 2023, then soared by 49 bps to 12.88% in 2024, then soared by 78 bps to 22.9% in 2025.
- Per Business Quant data, the three most recent EBITDA Margin figures were 22.9% in Q4 2025, 27.15% in Q3 2025, and 16.22% in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 11.58% |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 21.68% |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 15.86% |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 11.94% |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 2.18% |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -290.47% |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -2.69% |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -218,381.69% |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -15,327.78% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 22.90% |
| Sep 30, 2025 | -27.15% |
| Jun 30, 2025 | -16.22% |
| Mar 31, 2025 | 4.98% |
| Dec 31, 2024 | 12.88% |
| Sep 30, 2024 | -14.33% |
| Jun 30, 2024 | 50.21% |
| Mar 31, 2024 | 0.01% |
| Dec 31, 2023 | 8.66% |
| Jun 30, 2023 | -16.99% |
| Dec 31, 2022 | 8.73% |
| Sep 30, 2022 | 7.78% |
| Jun 30, 2022 | -2.19% |
| Mar 31, 2022 | 11.45% |
| Dec 31, 2021 | 0.01% |
| Sep 30, 2021 | 11,109.79% |
| Jun 30, 2021 | 1.11% |
| Mar 31, 2021 | 15.86% |
| Dec 31, 2020 | 0.02% |
| Sep 30, 2020 | 12,647.48% |